Sat Sep 20 09:21:07 UTC 2025: Okay, here’s a summary and a rewritten news article based on your text:

**Summary:**

A recent study indicates that the drug Mounjaro shows promise in treating Type 2 diabetes in children as young as 10. The drug has been found to effectively lower blood sugar and promote weight loss in this age group. Manufacturer Eli Lilly is seeking to broaden the drug’s approved use to include pediatric patients.

**News Article:**

**Mounjaro Shows Promise in Treating Type 2 Diabetes in Children, Study Finds**

**[City, State] –** A new study suggests that the drug Mounjaro could be a significant tool in the fight against Type 2 diabetes in children. The research, unveiled [mention conference or journal if available], indicates that Mounjaro, manufactured by Eli Lilly, can effectively lower blood sugar levels and reduce weight in children as young as 10 diagnosed with the disease.

The findings come as Eli Lilly seeks to expand the approved use of Mounjaro, currently prescribed for adults with Type 2 diabetes, to include younger patients.

[Include direct quote from the study if you have it]

“The results of this study are encouraging,” said [Name and Title of a researcher involved, if available]. “We observed significant improvements in both blood sugar control and weight management in the children who participated.”

Type 2 diabetes, once considered an adult-onset disease, is increasingly diagnosed in children and adolescents, primarily due to rising rates of obesity and sedentary lifestyles. The condition can lead to serious long-term health complications, including heart disease, kidney damage, and nerve damage.

While the study’s findings are positive, experts caution that Mounjaro, like any medication, carries potential side effects and should be used under the close supervision of a physician. Further research is needed to fully understand the long-term effects of Mounjaro on children and adolescents.

Eli Lilly is expected to submit its data to regulatory agencies, such as the FDA, seeking approval for pediatric use. If approved, Mounjaro could offer a new treatment option for children struggling with Type 2 diabetes.

Read More